Journal Article

Biotin Induces Inactive Chromosome X Reactivation and Corrects Physiopathological Alterations in Beta-Propeller-Protein-Associated Neurodegeneration

Romero-Domínguez, José Manuel, Álvarez-Córdoba, Mónica, Suárez-Carrillo, Alejandra, Sánchez-Alcázar, José A., Romero-González, Ana, García-Verdugo, José Manuel, Gómez-Fernández, David, Cilleros-Holgado, Paula, Piñero-Pérez, Rocío, López-Cabrera, Alejandra, Reche-López, Diana, González-Granero, Susana

2025

Overview

Neurodegeneration with brain iron accumulation (NBIA) involves a group of rare neurogenetic disorders often linked with iron overload in the basal nuclei of the brain presenting with spasticity, dystonia, muscle rigidity, neuropsychiatric symptoms, and retinal degeneration. Among NBIA subtypes, beta-propeller-protein-associated neurodegeneration (BPAN) is associated with mutations in the autophagy gene WDR45 (WD repeat domain 45). Previously, we demonstrated that WDR45 mutations in BPAN cellular models impaired autophagy, iron metabolism, and cell bioenergetics. In addition, antioxidant supplementation partially improved cell physiopathology; however, autophagy and cell bioenergetics remained affected. In this work, we explored the possibility of expressing the normal WDR45 allele present in the inactive chromosome X (Xi) of BPAN cells through treatment with epigenetic modulators. The aim of this study was to demonstrate whether biotin, an epigenetic nutrient, was able to restore the expression levels of WDR45 by a mechanism involving Xi reactivation and, consequently, correct BPAN defects. Our study demonstrated that biotin supplementation increases histone biotinylation and allows for the transcription of the WDR45 allele in Xi. Consequently, all physiopathological alterations in BPAN cells were notably corrected. The reactivation of Xi by epigenetic modulators can be a promising approach for the treatment of BPAN and other X-linked diseases.

• Publisher: MDPI AG,MDPI
• Subject: Analysis / Autophagy / Autophagy - drug effects / B cells / Bioenergetics / Biotin / Biotin - pharmacology / Carrier Proteins - genetics / Carrier Proteins - metabolism / Chromosomes / Chromosomes, Human, X - genetics / Enzymes / Epigenesis, Genetic - drug effects / Epigenetic inheritance / Epigenetics / Fibroblasts / Gene expression / Genes / Genetic aspects / Genetic research / Histones - metabolism / Homeostasis / Humans / Iron Metabolism Disorders - genetics / Iron Metabolism Disorders - metabolism / Lipid peroxidation / Lipids / Metabolism / Mutation / Neuroaxonal Dystrophies - drug therapy / Neuroaxonal Dystrophies - genetics / Neuroaxonal Dystrophies - metabolism / Neuroaxonal Dystrophies - pathology / Neurodegeneration / Patients / Physiological aspects / Protein expression / Proteins / X Chromosome Inactivation - drug effects